Key result
PCOS links to ~26% higher ischemia modified albumin in non-obese young girls versus healthy controls.
Why the study?
Are serum ischemia modified albumin (IMA) levels elevated in adolescent and young girls with PCOS compared to healthy controls?
Case-Control (n=82)
Are serum ischemia modified albumin (IMA) levels elevated in adolescent and young girls with PCOS compared to healthy controls?
Absolute Event Rate: 0.44% vs 0.35%
p-value: p=<0.001
Serum IMA levels are elevated in non-obese adolescents and young girls with PCOS, suggesting increased oxidative stress which may contribute to future cardiovascular risk.
Suggests oxidative stress in non-obese adolescent PCOS; hypothesis-generating for IMA as early CV risk marker requiring prospective studies.
Objective The pathophysiologic features of polycystic ovary syndrome (PCOS) seem to be a combination of genetic predisposition and environmental factors. However, data regarding the exact effect of oxidative stress on PCOS is conflicting. This cross sectional and case-control study was designed to compare the serum ischemia modified albumin (IMA) levels in adolescent and young girls with and without PCOS. Methods A total of 41 non-obese adolescents and young girls (15–21 years) diagnosed as PCOS and 41 age and body mass index (BMI) matched controls were enrolled to study. The main features of PCOS and markers of chronic inflammation were determined together with serum IMA levels at the time of study enrollment. Results The C-reactive protein and neutrophil-to-lymphocyte ratio were within the normal ranges and also there were no significant difference between the two groups (p>0.05). Serum levels of IMA were significantly increased in adolescents with PCOS respect to healthy controls (0.44±0.12 versus 0.35±0.10 absorbance units, p<0.001). And also there was a significant positive correlation between serum IMA and BMI in all groups (r=0.274, p=0.013). Conclusion Serum IMA levels were higher in PCOS patients than in the healthy controls. This elevation may contribute to the increased cardiovascular diseases risk in PCOS patients.
No takes yet. Share an insight, caveat, or question.
Kösem et al. (2018) conducted a case-control in Polycystic ovary syndrome (n=82). Polycystic ovary syndrome vs. Healthy controls was evaluated on Serum ischemia modified albumin (IMA) levels (p=<0.001). Polycystic ovary syndrome in non-obese adolescent and young girls was associated with significantly higher serum ischemia modified albumin levels compared to healthy controls (0.44 vs 0.35 absorbance units, p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: